Liraglutide, a glucagon-like peptide-1 receptor agonist, ameliorates inflammation and apoptosis via inhibition of receptor for advanced glycation end products signaling in AGEs induced chondrocytes
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Liraglutide, a glucagon-like peptide-1 receptor agonist, ameliorates inflammation and apoptosis via inhibition of receptor for advanced glycation end products signaling in AGEs induced chondrocytes ; volume:25 ; number:1 ; day:30 ; month:7 ; year:2024 ; pages:1-11 ; date:12.2024
BMC musculoskeletal disorders ; 25, Heft 1 (30.7.2024), 1-11, 12.2024
- Creator
-
Zhang, Xianyu
Jiang, Jian
Xu, Jiajia
Chen, Jian
Gu, Yuntao
Wu, Guobao
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12891-024-07640-6
- URN
-
urn:nbn:de:101:1-2410230832251.637792831712
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhang, Xianyu
- Jiang, Jian
- Xu, Jiajia
- Chen, Jian
- Gu, Yuntao
- Wu, Guobao
- SpringerLink (Online service)
Other Objects (12)
Glucagon-like peptide-1 receptor agonist, liraglutide, attenuated retinal thickening in spontaneously diabetic Torii fatty rats
Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cells
Effects of the long-acting glucagon-like peptide-1 receptor agonist liraglutide in adolescent pigs with impaired glucose-dependent insulinotropic polypeptide receptor function
Effects of the long-acting glucagon-like peptide-1 receptor agonist liraglutide in adolescent pigs with impaired glucose-dependent insulinotropic polypeptide receptor function
Correction: Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cells
Effects of the glucagon-like peptide-1 receptor agonist liraglutide in juvenile transgenic pigs modeling a pre-diabetic condition
Butyrate Modulates Inflammation in Chondrocytes via GPR43 Receptor
Contemporary Classification of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RAs)
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Production of interleukin-1 receptor antagonist by human articular chondrocytes
Regulation endothelialer "Adhäsionsmoleküle durch RAGE (receptor for advanced glycation endproducts)"
Untersuchungen zum Ectodomain shedding des Receptor for advanced glycation endproducts
Glucagon-like peptide-1 receptor agonist, liraglutide, attenuated retinal thickening in spontaneously diabetic Torii fatty rats
Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cells
Effects of the long-acting glucagon-like peptide-1 receptor agonist liraglutide in adolescent pigs with impaired glucose-dependent insulinotropic polypeptide receptor function
Effects of the long-acting glucagon-like peptide-1 receptor agonist liraglutide in adolescent pigs with impaired glucose-dependent insulinotropic polypeptide receptor function
Correction: Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cells
Effects of the glucagon-like peptide-1 receptor agonist liraglutide in juvenile transgenic pigs modeling a pre-diabetic condition
Butyrate Modulates Inflammation in Chondrocytes via GPR43 Receptor
Contemporary Classification of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RAs)
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Production of interleukin-1 receptor antagonist by human articular chondrocytes
Regulation endothelialer "Adhäsionsmoleküle durch RAGE (receptor for advanced glycation endproducts)"
Untersuchungen zum Ectodomain shedding des Receptor for advanced glycation endproducts
Glucagon-like peptide-1 receptor agonist, liraglutide, attenuated retinal thickening in spontaneously diabetic Torii fatty rats
Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cells
Effects of the long-acting glucagon-like peptide-1 receptor agonist liraglutide in adolescent pigs with impaired glucose-dependent insulinotropic polypeptide receptor function
Effects of the long-acting glucagon-like peptide-1 receptor agonist liraglutide in adolescent pigs with impaired glucose-dependent insulinotropic polypeptide receptor function
Correction: Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cells
Effects of the glucagon-like peptide-1 receptor agonist liraglutide in juvenile transgenic pigs modeling a pre-diabetic condition
Butyrate Modulates Inflammation in Chondrocytes via GPR43 Receptor
Contemporary Classification of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RAs)
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Production of interleukin-1 receptor antagonist by human articular chondrocytes
Regulation endothelialer "Adhäsionsmoleküle durch RAGE (receptor for advanced glycation endproducts)"